Patent · US Active

Bacteriophage engineering via semi-synthesis

US11891630B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 7, 2018
Grant dateFeb 6, 2024
Priority date
Expiry dateJul 4, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/202
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides methods of generating recombinant bacteriophage genomes via semi-synthesis. Specifically, the present technology provides methods of integrating a heterologous nucleic acid sequence into a bacteriophage genome, and isolating recombinant bacteriophages that express the heterologous nucleic acid sequence.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.